Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Metabolism of BIBR 953 and BIBR 1048 in Healthy Volunteers
NCT02171442Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2002
- Primary completion
- May 2002
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dabigatran etexilate oral solution in thromboembolism, sponsored by Boehringer Ingelheim. Started Apr 2002; status: completed.
02
Drugs
dabigatran etexilate oral solution
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02171442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02171442.